Latest GM & Biosafety Resources

The African Centre for Biosafety (ACB) is relieved to learn that Monsanto has withdrawn its application to conduct GM canola field trails in South Africa. GM Canola is predominantly grown in the USA, Canada and Australia. The global market for GM canola, used principally for cooking oils and animal feed, is estimated to be worth […]

South African GM Grapevine field trials to go ahead Press release: African Centre for Biosafety and Earthlife Africa eThekwini7 August 2009 South African authorities have given the go-ahead for open-air field trials of grapevines genetically modified (GM) to resist fungal disease, despite the failure of fungal resistant grapevines in German trials several years ago. The […]

“The African Centre for Biosafety (ACB) has been handed a document of the Common Market for Eastern and Southern Africa (COMESA) titled ‘Draft Policy Statements and Guidelines for commercial plantings of GMOs, Trade in GMOs and Emergency Food aid with GMO content.” The Policy intends to undermine and displace more than a decade’s worth of […]

A 16-page booklet by Edward Hammond. Read here. View the press release here.

The African Centre for Biosafety (ACB) condemns the decision by the Minister of Agriculture, Fisheries and Forestry to allow GM cassava field trials to go ahead in South Africa. This despite SA’s GMO regulatory body rejecting such trials more than three years ago. The field trials involve cassava genetically modified to control starch content. On […]

German pharmaceutical Schwabe announces withdrawal of 5 pelargonium patents The African Centre for Biosafety (ACB), the Berne Declaration (BD) and the Church Development Service (EED) welcome the announcement by Schwabe today that it will not pursue five pelargonium related patents granted to it by the European Patent Office EPO). Mariam Mayet, African Center for Biosafety […]

Pelargonium: EPO publishes grounds for Schwabe patent revocation (24.04.2010) The written decision setting out the grounds for the revocation of the Schwabe Pharmaceuticals Pelargonium Patent (EP02777223), has been published by the European Patent Office. As expected, the decision fully confirms the arguments presented by the Opponents during the hearing. The EPA reiterates its view that […]

Monsanto has made an application to the South African GMO authorities for permission to import Smartstax maize, one of the most controversial and risky GMOs ever produced for commercial use. The ACB recently published a report featuring Smartstax titled ‘The stacked gene revolution: A biosafety nightmare’. We pointed out that while the majority of commercially […]

From the Cape Times Newspaper – January 28, 2010 Edition 1, a small Eastern Cape community are elated after taking on a German pharmaceutical giant over a patent to produce extracts from two local plant species – and winning. “This is the first time that a patent is challenged successfully by Africans. It ends Schwabe’s […]

In a damning and ground breaking ruling, South Africa’s GM body, the Executive Council (EC), has rejected attempts by the Agriculture Research Council (ARC) to bring GM potatoes to the South African market. The EC cited no less than 11 biosafety and socio economic and agronomic concerns for rejecting ARC’s commercial release application. These support […]

Media Release by the African Centre for Biosafety Johannesburg 1 October 2009 The African Centre for Biosafety (ACB) has today released a report exposing the patents and players involved in appropriating key African food crops to produce genetically modified (GM) climate crops. According to the report, biotechnology is being used to identify ?climate genes? in […]

Genetically Modified (GM) crops, already used extensively in South Africa, are being promoted by the biotech industry through their philanthropic conduits such as the Bill and Melinda Gates and Warren Buffet foundations as the principle solution to food insecurity in Africa. The industrialistion of African agriculture that this would entail is more likely to exacerbate […]